SS09.5 IHPBA Meets ILCA: New Therapies for HCC

SS09.5 IHPBA Meets ILCA: New Therapies for HCC

Hepatocellular carcinoma, Resection, Outcomes, vascular reconstruction

Resecting the Unresectable? Hepatocellular Carcinoma: Is it Oncologically Worthwhile?

Albert Chan - Hong Kong

Corporate Partners

Ethicon logo
Angiodynamics logo
Sirtex logo
Baxter logo

If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org

Find out more